Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanli Hou

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Neuro-Oncology|December 4, 2014
Protein kinase A-dependent phosphorylation of Dock180 at serine residue 1250 is important for glioma growth and invasion stimulated by platelet derived-growth factor receptor αHaizhong Feng, Yanxin Li, Yuhua Yin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2024
Genomic Profiling and Immune Phenotyping of Neuroendocrine Bladder CancerJingyu Zang, Akezhouli Shahatiaili, Mei-Chun Cai, et al.
Cancer Genetics|October 14, 2017
A novel TRIP11-FLT3 fusion in a patient with a myeloid/lymphoid neoplasm with eosinophiliaAlfred Chung, Yanli Hou, Robert S Ohgami, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 23, 2017
Long-read genome sequencing identifies causal structural variation in a Mendelian diseaseJason D Merker, Aaron M Wenger, Tam Sneddon, et al.
Blood Advances|September 10, 2021
Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistanceJustin Anthony Chen, Yanli Hou, Krishna M Roskin, et al.
BMC Cancer|April 10, 2022
A multicenter noninferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stage IA1 with LVSI, IA2): study protocol of the LAUNCH 1 trialXin Wu, Hao Feng, Shujun Gao, et al.
Trials|April 9, 2022
A multicenter non-inferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stages IB1, IB2, and IIA1): study protocol of the LAUNCH 2 trialXin Wu, Ling Qiu, Weihua Lou, et al.
Trials|August 17, 2023
A multicenter noninferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stage IB3 and IIA2): study protocol of the LAUNCH 3 trialXin Wu, Hailin Yu, Yongrui Bai, et al.
Blood Advances|October 31, 2018
Impact of somatic and germline mutations on the outcome of systemic mastocytosisJavier I Muñoz-González, María Jara-Acevedo, Iván Alvarez-Twose, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Neuro-Oncology|December 4, 2014
Protein kinase A-dependent phosphorylation of Dock180 at serine residue 1250 is important for glioma growth and invasion stimulated by platelet derived-growth factor receptor αHaizhong Feng, Yanxin Li, Yuhua Yin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2024
Genomic Profiling and Immune Phenotyping of Neuroendocrine Bladder CancerJingyu Zang, Akezhouli Shahatiaili, Mei-Chun Cai, et al.
Cancer Genetics|October 14, 2017
A novel TRIP11-FLT3 fusion in a patient with a myeloid/lymphoid neoplasm with eosinophiliaAlfred Chung, Yanli Hou, Robert S Ohgami, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 23, 2017
Long-read genome sequencing identifies causal structural variation in a Mendelian diseaseJason D Merker, Aaron M Wenger, Tam Sneddon, et al.
Blood Advances|September 10, 2021
Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistanceJustin Anthony Chen, Yanli Hou, Krishna M Roskin, et al.
BMC Cancer|April 10, 2022
A multicenter noninferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stage IA1 with LVSI, IA2): study protocol of the LAUNCH 1 trialXin Wu, Hao Feng, Shujun Gao, et al.
Trials|April 9, 2022
A multicenter non-inferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stages IB1, IB2, and IIA1): study protocol of the LAUNCH 2 trialXin Wu, Ling Qiu, Weihua Lou, et al.
Trials|August 17, 2023
A multicenter noninferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stage IB3 and IIA2): study protocol of the LAUNCH 3 trialXin Wu, Hailin Yu, Yongrui Bai, et al.
Blood Advances|October 31, 2018
Impact of somatic and germline mutations on the outcome of systemic mastocytosisJavier I Muñoz-González, María Jara-Acevedo, Iván Alvarez-Twose, et al.
Pageof 9